Please assess the completion status of the following clinical trial:

Trial Title: Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 10 years or older~* Marfan syndrome according to international criteria Signed informed consent~Exclusion Criteria:~* Previous surgery of the ascending aorta, or surgery planned~* Non echogenicity~* Contre-indication lactose~* Pregnancy on going or planned within 3 years~* Breast feeding~* Participation in another clinical study~* Non member of the social security or CMU

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A: Placebo (Type: PLACEBO_COMPARATOR): placebo
- B: Losartan (Type: ACTIVE_COMPARATOR): Losartan

Based on this trial design, predict the completion outcome and termination type (if applicable).